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Abstract 
Intraosseous (IO) access is an alternative way of administering fluid and drug and also taking biopsies needed 
for clinical and laboratory tests in cases when peripheral venous access couldn’t be established. The IO route 
was successfully secured in all cases with a significant shorter time of vascular access insertion, shorter length 
of stay and reduction in mortality in IO group vs. IV group.  IO access was first used in 1922. This technique 
was widely used during 1940’s when emergency medical care was routinely needed for seriously injured 
patients in World War II. Since 1950’s after the introduction of peripheral venous access technique IO access 
lost its actuality. In management of Pediatric emergencies intravascular (venous) access is prior but 
sometimes establishing peripheral venous access is impossible or it may take too much time because of 
anatomical or physiological characteristics, such as an excessive subcutaneous fatty tissue and veins with a 
small diameter. Vasoconstriction, reduction of circulating blood volume and peripheral venous collapse takes 
place during cardiopulmonary arrest, septic or hypovolemic shock and prolonged status epilepticus. This 
features alone or in combination can make venous catheterization impossible.  
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For pediatric resuscitation, vascular access must be established quickly, often in difficult circumstances. 
Alternative methods of peripheral access, such as umbilical catheter, central venous lines, venous cut-down, and 
ultrasound guided access, may be poor options because of the patient’s age or condition, the urgency of 
resuscitation, and/or the skill of available clinicians. Anatomically, the described site is suggested to offer a safe 
alternative access point for emergency infusion in severely hypovolemic newborns and infants, without the risk 
of damage to any anatomical structures. IO access complications are infection - cellulites, abscess, 
osteomyelitis and fracture. The most widespread complication is extravasation, which, if left unidentified, can 
cause compartment syndrome. The EZ-IO® device is easy to use and requires minimal training. These studies 
suggest that the EZ-IO® is an easy to use, easy to learn tool that can be used successfully in resuscitation 
scenarios with minimal training.  It is evident that blood samples drawn immediately after intraosseous 
cannulation can provide accurate laboratory and blood bank data to aid in resuscitation. More recently, the 
pharmacokinetics of intraosseous drug delivery has been compared with central venous drug delivery. 
Keyword: Intraosseous (IO) access; Venous access; Intraosseous drug delivery. 
1. Introduction 
Intraosseous (IO) access is an alternative way of administering fluid and drug and also taking biopsies needed 
for clinical and laboratory tests in cases when peripheral venous access couldn’t be established. The cornerstone 
of emergency management of sepsis is early, goal-directed therapy. The effect of intraosseous (IO) vs. 
intravenous (IV) access for resuscitation of patients with septic shock admitted to pediatric intensive care unit 
[1]. The IO route was successfully secured in all cases with a significant shorter time of vascular access 
insertion, shorter length of stay and reduction in mortality in IO group vs. IV group. In pediatric emergencies, as 
in case of shock, the use of IO route is recommended to get rapid vascular access as soon as possible, as it 
revealed better outcome [1]. IO access was first used in 1922. This technique was widely used during 1940’s 
when emergency medical care was routinely needed for seriously injured patients in World War II [9-12]. Since 
1950’s after the introduction of peripheral venous access technique IO access lost its actuality [11]. In 
management of Pediatric emergencies intravascular (venous) access is prior but sometimes establishing 
peripheral venous access is impossible or it may take too much time because of anatomical or physiological 
characteristics, such as an excessive subcutaneous fatty tissue and veins with a small diameter [11]. 
Vasoconstriction, reduction of circulating blood volume and peripheral venous collapse takes place during 
cardiopulmonary arrest, septic or hypovolemic shock and prolonged status epilepticus. This features alone or in 
combination can make venous catheterization impossible [11-13]. During 80’s it was revealed that in pediatric 
emergency care peripheral venous catheterization wasn’t always effective. There was a need for finding 
alternative way. After reviewing the literature [11] it was clear that the IO access was the only alternative way 
for administration of fluids and drugs fast, effectively and with minimal side effects. American Heart 
Association (AHA) and American Academy of Pediatrics (AAP) added pediatric and neonatal resuscitation 
chapter in Advanced Cardiac Life Support (ACLS) guideline in which IO access is discussed as the only 
alternative way for fluid and drug administration [11,16,18]. In 2009, American college of critical care 
medicine revised sepsis guidelines in which IO insertion is discussed as an alternative way for maintaining 
hemodynamic stability in children and newborns [1-3]. Some research suggests that IO access is successful in 
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more than 90% of cases, which is an important clinical indicator. Moreover, IO insertion is performed in less than 
2 minutes if it’s done by skilled professional and the equipment is of high quality [15-20]. This is why the IO 
access is thought as the alternative way for fluid and drug administration in complicated cases or when 
peripheral venous catheterization is impossible [10-15]. Intraosseous line (IO) use has been described   in 
prehospital settings too, with some studies in the emergency department (ED). However, population-based 
studies describing IO line use across diverse ED and hospital settings are sparse, and the true incidence of 
complications remains unknown [16]. It was a retrospective cohort study using administrative data from 450 
California hospitals and ED.s. Two hundred ninety-one children had IO lines placed in 90 hospitals, including 
239 in the ED and 52 inpatient. There were 6,660,564 pediatric ED visits and 2,276,231 pediatric admissions, 
resulting in an incidence of IO line placement of 0.04 per 1000 ED visits and 0.02 per 1000 admissions. 
Mortality was 37% among patients with IO line placement. The most common diagnoses included cardiac arrest 
(34%), trauma (19%), and respiratory failure (6%). Types of hospital in which IO lines were placed included 
children’s hospitals 14%, general hospitals 86%, and rural hospitals 7.9%. No complications were identified 
[16]. Intraosseous vascular access is a time-tested procedure which has been incorporated into the 2010 
American Heart Association Guidelines for Cardiopulmonary Resuscitation [11-16]. Intravenous access is often 
difficult to achieve in shock patients, and central line placement can be time consuming. Intraosseous vascular 
access, however, can be achieved quickly with minimal disruption of chest compressions. Newer insertion 
devices are easy to use, making the intraosseous route an attractive alternative for venous access during a 
resuscitation event. It is critical   that anesthesiologists, who are often at the forefront of patient resuscitation, 
understand how to properly use this potentially life-saving procedure [18]. The overall incidence of IO line use 
in the ED and hospital setting is low, but IO line access is used in a variety of different hospital and ED settings 
for high-acuity conditions. No IO line complications were identified [16]. Intraosseous (IO) access is a standard 
of care for pediatric emergencies in the absence of conventional intravenous access. Intraosseous needles 
provide access for resuscitation fluids and medications and are often placed in the emergency department [11-
13-17]. However, there are no studies to date that describe the characteristics of pediatric IO needle recipients 
or their dispositions and outcomes. This study examined the characteristics and disposition of children 
following IO needle placement by prehospital and emergency room teams before being transported to a 
children’s hospital [17]. However, of those who experienced a complication, 27% were due to infiltration of the 
IO needle. Of those admitted to hospital, 58% (n = 83) were ultimately discharged home. Intraosseous access 
provides a safe and reliable method for rapidly achieving a route for administration of medications, fluids and 
blood products. It is a lifesaving measure with most IO needles successfully placed by referring facilities prior 
to transport, with few reported complications [17]. There was a case of 2 months old critically ill child who 
developed cardiac arrest while securing central venous access under ultra-sonographic technique. Successful 
resuscitation by administering fluid and drugs through prompt establishment of intra osseous access saved the 
life of an infant [19]. Difficulties to establish a venous access may also occur in routine pediatric anesthesia and 
lead to hazardous situations. Intraosseous infusion is a well-tolerated and reliable but rarely used alternative 
technique in this setting. According to recent surveys, severe complications of intraosseous infusion stay a rare 
event [17-20]. Minor complications and problems in getting an intraosseous infusion started on the other side 
seem to be more common than generally announced. The EZ-IO intraosseous infusion system has received 
expanded EU CE mark approval for an extended dwell time of up to 72 h and for insertion in pediatric patients 
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in the distal femur.  Key values of blood samples for laboratory analysis can be obtained with only 2 ml of 
blood/marrow waste and do also offer reliable values using an I-Stat point-of-care analyzer [15,20]. Most 
problems in using an intraosseous infusion are provider-dependent. In pediatric anesthesia, the perioperative 
setting should further contribute to reduce these problems. Nevertheless, regular training, thorough anatomical 
knowledge and prompt availability especially in the pediatric age group are paramount to get a seldom used 
technique work properly under pressure. More longitudinal data on large cohorts were preferable to further 
support the safety of the intraosseous infusion technique in pediatric patients [20,21]. Intraosseous access (IO) 
is becoming increasingly accepted in adult populations as an alternative to peripheral vascular access; however, 
there is still insufficient evidence in large patient groups supporting its use. (არა მარტო ბავშვებში)!!! IO 
access can be used to administer a wide variety of life-saving medications quickly, easily and with low-
complication rates [11,16,18,22]. This highlights its valuable role as an alternative method of obtaining vascular 
access, vital when resuscitating the critically injured trauma patient [22]. Intraosseous (IO) needle placement is 
an alternative for patients with difficult venous access. The purpose of this retrospective study was to examine 
indications and outcomes associated with IO use at a Level 1 trauma center (January 2008-May 2015). Data 
points included demographics, time to insertion, intravenous (IV) access points, indications, infusions, hospital 
and intensive care unit length of stay, and mortality. Of 68 patients with IO insertion analyzed (63.2% blunt 
trauma, 29.4% penetrating trauma, and 7.4% medical), 56 per cent were hypotensive on arrival and 38.2 per 
cent asystolic. The most common indications for IO infusion were difficult IV access (69%) and rapid sequence 
intubation (20.6%). The median time to IO access was three minutes. IV access was gained after IO in 72.1 per 
cent of patients. Through IO access, 30.9 per cent patients received crystalloid, 29.4 per cent received 
Advanced Care Life Support (ACLS) medications, 25 per cent rapid sequence intubation medications, 20.6 per 
cent blood products, and 2.9 per cent seizure medications. Overall,80.9 per cent were 
intubated in the Emergency Department (ED), 26.5 per cent had ED thoracotomy, and 20.6 per cent had a 
laparotomy. Median crystalloid infused through IO was 180 cc in pediatric patients and 1 L in adults, 
respectively. Extravasation, the most common complication, was experienced by 7.4 per cent of patients. In 
hospital mortality was 72.9 per cent. IO access should be considered when there is a need for rapid intervention 
requiring vascular access [24]. For the pediatric cohort, use of a semiautomatic IO access device in place of a 
manual device offered no statistically significant difference in first-attempt success (3.3%) or in success per 
attempt (13.0%). However, the rate at which IO access was used by emergency medical services providers more 
than tripled with use of the semiautomatic device [25]. Vascular access is a potentially life-saving procedure 
that is a mainstay of emergency medicine practice. There are a number of challenges associated with obtaining 
and maintaining vascular access, and the choice of the route of access and equipment used will depend on 
patient- and provider-specific factors. Timely and effective assessment and management of difficult-
access patients, pain control techniques that can assist vascular access, and contraindications to each type of 
vascular access can be discussed [26]. Intraosseous access is a rapid and effective route of fluid and drug 
administration. Its use has been proven in emergency medicine, pediatrics, and the military. We aimed to assess 
its performance and utilization against landmark-guided central venous catheter placement during inpatient 
medical emergencies [27]. We found information in various scientific publications about intraosseous device 
training which was added to standard central venous catheter training beginning in February 2012. Intraosseous 
were used as primary access in cardiac arrests and secondary access if central venous catheter placement failed 
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during noncardiac arrest emergencies. An online survey was conducted among intraosseous and central venous 
catheter operators to assess their experience and any barriers to use. In this study Seventy-nine adults had 
central access placement from February 2012 to July 2013. Sixty were during medical emergency team calls, 
and 19 were cardiac arrests. Thirty-one received intraosseous device, and 48 received a central venous catheter. 
First-pass success was significantly higher for intraosseous than for central venous catheter (90.3 vs 37.5%; 
95% CI, 80-101 vs 24-51; p<0.001). Mean placement times were significantly shorter for intraosseous than for 
central venous catheter (1.2 vs 10.7 min; p<0.001). There was a total of 33 intraosseous versus 169 central 
venous catheter attempts with fewer attempts on average per patient during intraosseous placement (1.1 vs 2.8; 
p<0.001). There were three intraosseous-related complications and 22 central venous catheter-related 
complications. This survey showed high satisfaction with intraosseous training and operation. Among the 
barriers cited, timely intraosseous kit acquisition was most common [27]. It is feasible to incorporate 
intraosseous use during medical emergency team calls. Intraosseous had significantly higher first-pass success 
rates and faster placement compared with central venous catheters. Intraosseous operators reported high 
satisfaction and confidence in its use. Prospective randomized studies comparing intraosseous and central 
venous catheter are warranted [27]. For pediatric resuscitation, vascular access must be established quickly, 
often in difficult circumstances. Alternative methods of peripheral access, such as umbilical catheter, central 
venous lines, venous cut-down, and ultrasound guided access, may be poor options because of the patient’s age 
or condition, the urgency of resuscitation, and/or the skill of available clinicians. When peripheral access fails 
after 3 attempts (or in 90 seconds), an intraosseous line offers emergency clinicians a fast and effective 
alternative for venous access in children of all ages. They can be inserted within 5 to 60 seconds, and they 
require little clinician experience or training and minimal equipment. The American Heart Association, the 
International Committee on Resuscitation, and the American College of Surgeons all recommend intraosseous 
line use [28]. Although contraindications include existing bone fracture or bone disease, complication rates are 
similar to central venous catheters. This review looks at the guide- lines, recommendations, and evidence on 
using intraosseous lines in pediatric patients and gives information about mechanical devices used, techniques 
for insertion, and possible complications [28]. Studies have shown that the venous system tends to collapse 
during hypovolemic shock. The use of the bone marrow space for infusions is an effective alternative, with the 
tibial insertion site being the norm. This study was conducted to determine a quick intraosseous infusion 
method that could be an alternative to the tibial route in neonates during emergency situations [20,29]. 
Anatomically, the described site is suggested to offer a safe alternative access point for emergency infusion in 
severely hypovolemic newborns and infants, without the risk of damage to any anatomical structures [29,30]. 
Gaining   vascular access in a neonate during   cardiopulmonary resuscitation is crucial and challenging.  
Intraosseous (IO) access can offer a fast and reliable method for achieving emergency access for fluids and 
drugs when venous access fails in a critically ill child.  IO access can however result in rare, but serious adverse 
events including compartment syndrome and amputation [30-33]. There was a case resulting in leg amputation 
due to IO infusion in a neonate after resuscitation and therapeutic hypothermia. We compared 10 tibia X-rays in 
three age groups. The mean medullary diameter of the proximal tibia at the recommended site for IO access was 
7 mm in neonate,10 mm in 1- to 12-month-old infants, and 12 mm in 3- to 4-year-old children. This provides a 
narrow margin of safety for the correct positioning and the avoidance of dislodgement of the IO needle [10,31]. 
IO access complications are infection - cellulites, abscess, osteomyelitis and fracture. The most widespread 
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complication is extravasation, which, if left unidentified, can cause compartment syndrome [7]. IO access 
must be done in aseptic conditions to minimize complications. The catheter insertion site must be checked for 
extravasation before and after catheter insertion. Peripheral or central catheterization has to be done as soon 
as it’s possible. The perfect time for it is 24 hours [8]. In this research it was unable to study all the 
complications of IO access. The most common complication of IO access is infiltration [4]. Mortality rate is still 
high in patients in whom IO access wasn’t established before arriving to hospital (40%). We hope that mortality 
rate will significantly decrease with an implementation of   PALS guidelines [10]. Approximately 46.8% of 
patients had cardiovascular and respiratory arrest in combination [12]. IO access was established in cases in 
which attempt of venous catheterization was unsuccessful. From this research it is obvious that most of the 
patients survived and discharged from clinics [10]. It is interesting that this study was conducted before the 
PALS 2010 guidelines were approved, in which it is indicated that IO access must be established if 
venous catheterization is unsuccessful. During the study they found out that IO access was widely used for 
fluid and drug administration in pediatric population in 1985 [5]. IO access has advantages compared to central 
and peripheral catheterization: 1. IO access technique was used in 46,8% of cases with respiratory and 
cardiovascular arrest. 2. Respiratory failure - 17.5%. 3. Cardiovascular failure - 11.2% and finally 
sepsis/fever/dehydration - 9.1%.  The problem is that IO access can be used only for 24 hours [10]. The reason 
for which IO access is thought as an alternative way for peripheral catheterization is: Impossibility of peripheral 
venous catheterization in 53.1 % of cases, absence of perfusion in 33.6 %. Accidental removal of already 
established catheter in 6.3 % of cases [10]. The correct position of the IO needle should be confirmed by bone 
marrow aspiration and fluid bolus.  Unnecessary touching of the IO needle after fixing it in place should be 
avoided by inserting a luer lock catheter with a three-way stop-cock for IO drug and fluid administration.  
Regular observation of the circulation and possible swelling of the leg should be performed. The IO 
administration of inotropic infusions should also be avoided after the initial resuscitation phase. When treating 
with therapeutic hypothermia it may be wise to remove the IO needle much earlier than the currently 
recommended 24 h because of the problems in peripheral circulation and its monitoring [31]. Complication 
rates are estimated to be low, based on small patient series, model or cadaver studies, and case reports. 
However, user experience with IO use in real-life emergency situations might differ from the results in the 
controlled environment of model studies and small patient series [33]. Survey was performed of IO use in real-
life emergency situations to assess users’ experiences of complications [31-33]. In users’ recollection of real-
life IO use, perceived complications were more frequent than usually reported from model studies. The 
perceived difficulties with using IO could affect the willingness of medical staff to use IO. Therefore, user 
experience should be addressed both in education of how to use, and research and development of IOs [33]. 
2. Conclusion 
 Intraosseous cannulation is a time-tested procedure that will play a role in the resuscitation of patients in the 
future. Intravenous access is often difficult to achieve in shock patients and central line placement can be time 
consuming. This literature review has demonstrated that intraosseous vascular access can be achieved quickly 
and accurately in emergency situations. Given the efficiency of insertion combined with a favorable 
complication profile, there is clearly a role for intraosseous vascular access in the resuscitation of critically ill 
patients. Therefore, emergency care doctor should become familiar with intraosseous insertion techniques and 
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understand how to properly use this potentially life-saving procedure.The EZ-IO® device is easy to use and 
requires minimal training. These studies suggest that the EZ-IO® is an easy to use, easy to learn tool that can be 
used successfully in resuscitation scenarios with minimal training. It is evident that blood samples drawn 
immediately after intraosseous cannulation can provide accurate laboratory and blood bank data to aid in 
resuscitation. More recently, the pharmacokinetics of intraosseous drug delivery has been compared with 
central venous drug delivery. As per the 2010 AHA guidelines, all Advanced Cardiac Life Support medications 
are administered at the same doses regardless of route. Colloids have also been effectively administered through 
the intraosseous route. An analysis of hydroxyethyl starch pharmacokinetics demonstrated no significant 
difference between intravenous and intraosseous administration. 
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